Page last updated: 2024-08-21

nsc 65346 and Pancreatic Neoplasms

nsc 65346 has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastea, LI; Döppler, HR; Hollant, LMA; Reid, EM; Storz, P1

Other Studies

1 other study(ies) available for nsc 65346 and Pancreatic Neoplasms

ArticleYear
Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.
    Scientific reports, 2019, 11-12, Volume: 9, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Histones; Humans; Intracellular Signaling Peptides and Proteins; Mice; Pancreatic Neoplasms; Phosphorylation; Prognosis; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Pyrimidine Nucleosides; Signal Transduction; Survivin; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays

2019